-
-
-
-
-
-
-
European Commission approves SpringWorks' EZMEKLY for rare tumor condition
-
-
-
-
-
-
-
Eledon to present kidney transplant drug data at medical congress
-
-
-
-
-
-
-
Johnson & Johnson gets FDA priority review for bladder cancer treatment
-
-
-
-
-
-
-
Wallbridge begins phase 2 drilling at Martiniere gold project
-
-
-
-
-
-
-
Cue Biopharma reports additional response in head and neck cancer trial
-
-
-
-
-
-
-
FDA lifts partial clinical hold on Kezar Life Sciences hepatitis drug trial
-
-
-
-
-
-
-
ProKidney secures FDA alignment on accelerated approval pathway for rilparencel
-
71,225 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.